Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Current Leases: 2019-2020

Historic Current Leases for Larimar Therapeutics (LRMR) over the last 2 years, with Sep 2020 value amounting to $525,000.

  • Larimar Therapeutics' Current Leases rose 28.36% to $525,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $525,000, marking a year-over-year increase of 28.36%. This contributed to the annual value of $97,000 for FY2019, which is N/A change from last year.
  • Latest data reveals that Larimar Therapeutics reported Current Leases of $525,000 as of Q3 2020, which was down 11.17% from $591,000 recorded in Q2 2020.
  • Over the past 5 years, Larimar Therapeutics' Current Leases peaked at $618,000 during Q2 2019, and registered a low of $97,000 during Q4 2019.
  • In the last 2 years, Larimar Therapeutics' Current Leases had a median value of $467,500 in 2020 and averaged $441,667.
  • Within the past 5 years, the most significant YoY rise in Larimar Therapeutics' Current Leases was 28.36% (2020), while the steepest drop was 4.37% (2020).
  • Over the past 2 years, Larimar Therapeutics' Current Leases (Quarterly) stood at $97,000 in 2019, then grew by 28.36% to $525,000 in 2020.
  • Its Current Leases stands at $525,000 for Q3 2020, versus $591,000 for Q2 2020 and $410,000 for Q1 2020.